Differential regulation of intestinal and hepatic CYP3A by 1α,25‐dihydroxyvitamin D3: Effects on in vivo oral absorption and disposition of buspirone in rats-Reference-Cited by-同舟云学术

Differential regulation of intestinal and hepatic CYP3A by 1α,25‐dihydroxyvitamin D3: Effects on in vivo oral absorption and disposition of buspirone in rats

Published:2018-12-10 Issue:3 Volume:80 Page:333-342
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Maeng Han‐Joo¹,Doan Trang Nguyen Kieu¹,Yoon In‐Soo²^ORCID

Affiliation:

1. College of Pharmacy, Gachon University Incheon South Korea

2. Department of Manufacturing PharmacyCollege of Pharmacy, Pusan National University Busan South Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21505

Reference61 articles.

1. Development and validation of RP‐HPLC method for the determination of adefovir dipivoxil in bulk and in pharmaceutical formulation;Ahmed Z.;Journal of Chemistry,2009

2. In vitro determination of the CYP 3A4 activity in rat hepatic microsomes by liquid-phase extraction and HPLC-photodiode array detection

3. Vitamin D and its Major Metabolites: Serum Levels after Graded Oral Dosing in Healthy Men

4. Vitamin D in anxiety and affective disorders;Bicikova M.;Physiological Research,2015

5. Vitamin D supplementation for prevention of mortality in adults;Bjelakovic G.;The Cochrane Database of Systematic Reviews,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of an LC–MS/MS method for the determination of BLU-945, a fourth-generation EGFR tyrosine kinase inhibitor, in rat and mouse plasma: application to a pharmacokinetic study in rats;Journal of Analytical Science and Technology;2024-06-10

2. Impact of 1α,25-dihydroxyvitamin D3 on biodistribution and pharmacokinetics of L-carnitine and creatinine, organic cation/carnitine transporter 2 and organic cation transporter 2 biomarkers;Journal of Pharmaceutical Investigation;2024-02-07

3. Involvement of CYP3A4 and MDR1 in altered metabolism and transport of indinavir in 1,25(OH)2D3-treated Caco-2 cells;European Journal of Pharmaceutical Sciences;2023-04

4. Inhibitory effect of 20(S)-protopanaxadiol on cytochrome P450: Potential of its pharmacokinetic interactions in vivo;Biomedicine & Pharmacotherapy;2022-09

5. Impact of route-dependent phase-II gut metabolism and enterohepatic circulation on the bioavailability and systemic disposition of resveratrol in rats and humans: A comprehensive whole body physiologically-based pharmacokinetic modeling;Biomedicine & Pharmacotherapy;2022-07